Acute reversible neurological manifestations due to triflupromazine therapy. A report of three cases.
D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D009069:Movement Disorders / Q000139:chemically induced*; D012640:Seizures / Q000139:chemically induced*; D014273:Triflupromazine / Q000009:adverse effects*
D014273:Triflupromazine